留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

极速脉搏波技术在系统性红斑狼疮亚临床动脉粥样硬化中的评估价值及其临床相关因素研究

王星 陆芳 石彦 李阳 谢长好

王星, 陆芳, 石彦, 李阳, 谢长好. 极速脉搏波技术在系统性红斑狼疮亚临床动脉粥样硬化中的评估价值及其临床相关因素研究[J]. 中华全科医学, 2025, 23(7): 1192-1195. doi: 10.16766/j.cnki.issn.1674-4152.004095
引用本文: 王星, 陆芳, 石彦, 李阳, 谢长好. 极速脉搏波技术在系统性红斑狼疮亚临床动脉粥样硬化中的评估价值及其临床相关因素研究[J]. 中华全科医学, 2025, 23(7): 1192-1195. doi: 10.16766/j.cnki.issn.1674-4152.004095
WANG Xing, LU Fang, SHI Yan, LI Yang, XIE Changhao. Evaluation of ultrafast pulse wave technique in subclinical atherosclerosis in SLE and its clinical correlates[J]. Chinese Journal of General Practice, 2025, 23(7): 1192-1195. doi: 10.16766/j.cnki.issn.1674-4152.004095
Citation: WANG Xing, LU Fang, SHI Yan, LI Yang, XIE Changhao. Evaluation of ultrafast pulse wave technique in subclinical atherosclerosis in SLE and its clinical correlates[J]. Chinese Journal of General Practice, 2025, 23(7): 1192-1195. doi: 10.16766/j.cnki.issn.1674-4152.004095

极速脉搏波技术在系统性红斑狼疮亚临床动脉粥样硬化中的评估价值及其临床相关因素研究

doi: 10.16766/j.cnki.issn.1674-4152.004095
基金项目: 

安徽省卫生健康科研项目 AHWJ2023A20372

安徽省自然科学基金项目 2108085MH258

详细信息
    通讯作者:

    石彦,E-mail:1026238908@qq.com

  • 中图分类号: R593.241 R445.1

Evaluation of ultrafast pulse wave technique in subclinical atherosclerosis in SLE and its clinical correlates

  • 摘要:   目的  应用极速脉搏波技术评估不同活动度系统性红斑狼疮(SLE)患者的血管弹性并探究其相关危险因素。  方法  选取2020年10月—2024年4月就诊于蚌埠医科大学第一附属医院的116例SLE患者,根据SLE疾病活动性指数2000分为轻度活动组(57例)和中重度活动组(59例),纳入45名健康成年人作为对照组。测量各组的颈动脉内中膜厚度(IMT)、收缩期起始时的脉搏波传导速度(PWV-BS)及收缩期末的脉搏波传导速度(PWV-ES),比较3组颈动脉参数及临床资料,分析脉搏波传导速度(PWV)与各指标之间的相关性。  结果  3组间PWV-BS、PWV-ES比较,中重度活动组>轻度活动组>对照组(P<0.05)。PWV-BS与颈总动脉IMT(r=0.315, P < 0.001)、收缩压(r=0.190, P=0.041)、舒张压(r=0.191, P=0.040)呈正相关关系,PWV-ES与颈动脉分叉处IMT(r=0.274, P=0.003)、颈总动脉IMT(r=0.361, P < 0.001)、舒张压(r=0.252, P=0.006)呈正相关关系。  结论  SLE患者的颈动脉弹性减低明显早于健康者,极速脉搏波可定量评估SLE患者颈动脉弹性,且不受限于时期,这为临床早期动脉硬化评估提供了客观依据。

     

  • 图  1  SLE组与健康对照组ufPWV技术检查结果

    注:A为对照组,PWV-BS为3.38 m/s,PWV-ES为5.33 m/s;B为轻度活动组,PWV-BS为4.67 m/s,PWV-ES为7.61 m/s;C为中重度活动组,PWV-BS为5.25 m/s,PWV-ES为10.26 m/s。

    Figure  1.  Results of ufPWV technique examination in the SLE group and healthy control group

    表  1  3组研究对象性别和年龄比较

    Table  1.   Comparison of gender and age among three groups

    组别 例数 性别[例(%)] 年龄[M(P25, P75), 岁]
    男性 女性
    轻度活动组 57 7(12.28) 50(87.72) 42.00(34.00, 50.00)
    中重度活动组 59 3(5.08) 56(94.92) 39.00(30.50, 50.50)
    对照组 45 5(11.11) 40(88.89) 40.00(34.00, 46.00)
    统计量 2.015a 1.261b
    P 0.365 0.532
    注:a为χ2值,bH值。
    下载: 导出CSV

    表  2  3组研究对象临床资料比较[M(P25, P75)]

    Table  2.   Comparison of clinical data among three groups[M(P25, P75)]

    组别 例数 SBP(mmHg) DBP(mmHg) TC(mmol/L) TG(mmol/L) HDL(mmol/L) LDL(mmol/L)
    轻度活动组 57 123.00(115.00, 133.00) 79.00(72.00, 88.00) 4.27(3.64, 4.82) 1.37(1.04, 2.13) 1.22(0.97, 1.44) 2.34(1.98, 2.66)
    中重度活动组 59 129.00(117.50, 145.50)a 82.00(73.00, 97.00)a 4.38(3.33, 5.40) 1.31(0.81, 1.90) 1.30(1.01, 1.56) 2.52(1.98, 3.17)
    对照组 45 118.00(112.00, 125.00) 76.00(72.00, 81.00) 4.11(3.73, 4.50) 1.32(1.06, 1.80) 1.21(0.97, 1.48) 2.29(1.89, 2.86)
    统计量 10.471b 7.412b 2.879b 0.933b 1.049b 3.608b
    P 0.005 0.025 0.237 0.627 0.592 0.165
    组别 例数 APO(a)(g/L) APO(b)(g/L) LP(a)(mg/L) CRP(mg/L) ESR(mm/h) 病程(月)
    轻度活动组 57 1.06(0.87, 1.23) 0.79(0.67, 0.90) 155.00(63.00, 280.00)a 4.60(1.91, 7.70)a 34.00(28.00, 40.00) 60.00(12.00, 132.00)
    中重度活动组 59 1.17(0.86, 1.38) 0.85(0.69, 0.96) 151.00(102.00, 285.50)a 6.20(1.95, 23.00)ac 44.00(38.00, 50.00)c 96.00(12.00, 144.00)
    对照组 45 1.10(0.90, 1.28) 0.76(0.68, 0.96) 88.00(56.00, 220.00) 0.80(0.60, 2.00)
    统计量 1.305b 1.283b 6.400b 42.146b -4.562d 0.982d
    P 0.521 0.526 0.041 < 0.001 < 0.001 0.326
    注:与对照组比较,aP < 0.05;与轻度组比较,cP < 0.05;bH值,dZ值。1 mmHg=0.133 kPa。
    下载: 导出CSV

    表  3  SLE组左、右侧颈动脉IMT和PWV比较[M(P25, P75)]

    Table  3.   Comparison of left and right carotid IMT and PWV in the SLE group[M(P25, P75)]

    组别 例数 分叉处IMT(mm) 颈总动脉IMT(mm) PWV-BS(m/s) PWV-ES(m/s)
    右侧颈动脉 116 0.78(0.70, 0.81) 0.71(0.64, 0.77) 5.48(4.78, 6.38) 7.13(6.26, 8.17)
    左侧颈动脉 116 0.78(0.71, 0.82) 0.73(0.64, 0.78) 5.47(4.91, 6.02) 7.47(6.77, 8.46)
    Z -0.361 -1.800 -0.180 -1.785
    P 0.718 0.072 0.857 0.074
    下载: 导出CSV

    表  4  对照组左、右侧颈动脉IMT、PWV比较[M(P25, P75)]

    Table  4.   Comparison of left and right carotid IMT and PWV in the control group[M(P25, P75)]

    组别 例数 分叉处IMT(mm) 颈总动脉IMT(mm) PWV-BS(m/s) PWV-ES(m/s)
    右侧颈动脉 45 0.71(0.68, 0.75) 0.66(0.60, 0.68) 4.63(4.24, 4.88) 5.74(5.43, 6.34)
    左侧颈动脉 45 0.70(0.70, 0.73) 0.66(0.60, 0.70) 4.46(4.10, 4.86) 5.66(5.40, 5.89)
    Z -0.886 -1.595 -0.728 -1.506
    P 0.375 0.111 0.467 0.132
    下载: 导出CSV

    表  5  3组研究对象超声参数比较[M(P25, P75)]

    Table  5.   Comparison of ultrasonic parameters among three groups[M(P25, P75)]

    组别 例数 分叉处IMT(mm) 颈总动脉IMT(mm) PWV-BS(m/s) PWV-ES(m/s)
    对照组 45 0.71(0.69, 0.74) 0.65(0.60, 0.69) 4.48(4.02, 4.96) 5.75(5.34, 6.29)
    轻度活动组 57 0.75(0.71, 0.80)a 0.69(0.63, 0.74)a 5.22(4.75, 5.68)a 6.85(6.46, 7.66)a
    中重度活动组 59 0.79(0.73, 0.85)a 0.71(0.68, 0.76)ab 6.00(5.37, 6.55)ab 7.91(7.28, 8.73)ab
    H 22.400 37.215 73.939 81.189
    P < 0.001 < 0.001 < 0.001 < 0.001
    注:与对照组比较,aP < 0.05;与轻度组比较,bP < 0.05。
    下载: 导出CSV
  • [1] LAZAR S, KAHLENBERG J M. Systemic lupus erythematosus: new diagnostic and therapeutic approaches[J]. Annu Rev Med, 2023, 74(1): 339-352. doi: 10.1146/annurev-med-043021-032611
    [2] FANOURIAKIS A, TZIOLOS N, BERTSIAS G, et al. Update on the diagnosis and management of systemic lupus erythematosus[J]. Ann Rheum Dis, 2021, 80(1): 14-25. doi: 10.1136/annrheumdis-2020-218272
    [3] KATAYAMA Y, YANAI R, ITAYA T, et al. Risk factors for cardiovascular diseases in patients with systemic lupus erythematosus: an umbrella review[J]. Clin Rheumatol, 2023, 42(11): 2931-2941. doi: 10.1007/s10067-023-06608-6
    [4] OLIVEIRA C B, KAPLAN M J. Cardiovascular disease risk and pathogenesis in systemic lupus erythematosus[J]. Semin Immunopathol, 2022, 44(3): 309-324. doi: 10.1007/s00281-022-00922-y
    [5] MINANO S, GONZALEZ-CORREA C, MOLEON J, et al. Metabolic modulators in cardiovascular complications of systemic lupus erythematosus[J]. Biomedicines, 2023, 11(12): 3142. DOI: 10.3390/biomedicines11123142.
    [6] WU X L, ZHANG S M, JIN Y Z, et al. Sex-related differences in sitagliptin treatment in type 2 diabetes: results from the PROLOGUE trial[J]. Med Sci Monit, 2022, 28: e938030. DOI: 10.12659/MSM.938030.
    [7] 刁玉红, 刘志兴, 彭娟, 等. 超声极速成像技术评价烟雾病患者颈动脉血管弹性的临床应用价值[J]. 中国超声医学杂志, 2023, 39(1): 99-102.

    DIAO Y H, LIU Z X, PENG J, et al. Evaluation of carotid artery elasticity by hypervelocity ultrasound in patients with moyamoya disease[J]. Chinese Journal of Ultrasound in Medicine, 2023, 39(1): 99-102.
    [8] DZIEDZIC-OLEKSY H, MAZUREK A, BUGALA K, et al. Arterial stiffness and atherosclerosis in systemic lupus erythematosus patients[J]. Reumatologia, 2022, 60(3): 165-172. doi: 10.5114/reum.2022.117836
    [9] HONCHBERG M C. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus[J]. Arthritis Rheum, 1997, 40(9): 1725. DOI: 10.1002/art.1780400928.
    [10] 乔敏, 陆萍萍, 沈德娟. 颈动脉斑块报告和数据系统联合临床特征对脑卒中的预测价值[J]. 中国超声医学杂志, 2024, 40(9): 961-963.

    QIAO M, LU P P, SHEN D J. The predictive value of plaque reporting and data system combined with clinical features for stroke[J]. Chinese Journal of Ultrasound in Medicine, 2024, 40(9): 961-963.
    [11] CHITPET P, CHAIAMNUAY S, NARONGROEKNAWIN P. The effect of systemic lupus erythematosus (SLE) disease activity score and SLE disease activity index 2000-based remission states in patients with SLE on damage accrual[J]. Int J Rheum Dis, 2023, 26(12): 2509-2516. doi: 10.1111/1756-185X.14949
    [12] NELSON M C, CHANDRAKASAN S, PONDER L, et al. Clinical determinants of childhood onset systemic lupus erythematosus among early and peri-adolescent age groups[J]. Children, 2022, 9(12): 1865. DOI: 10.3390/children9121865.
    [13] 杨雅淇, 温军业, 高丽, 等. 极速脉搏波技术对SLE患者颈动脉弹性定量评价的初步研究[J]. 影像科学与光化学, 2021, 39(6): 823-826.

    YANG Y Q, WEN J Y, GAO L, et al. Preliminary study on the value of ultrafast pulse wave velocity in quantitative evaluation of carotid artery elasticity in patients with systemic lupus erythematosus[J]. Imaging Science and Photochemistry, 2021, 39(6): 823-826.
    [14] 安欣, 李宜函, 葛丽丽, 等. 极速脉搏波技术评价原发性干燥综合征患者颈动脉弹性[J]. 中国医学影像学杂志, 2022, 30(12): 1218-1223.

    AN X, LI Y H, GE L L, et al. Carotid artery elasticity in patients with primary Sjogren's syndrome evaluated by ultrafast pulse wave velocity[J]. Chinese Journal of Medical Imaging, 2022, 30(12): 1218-1223.
    [15] 孔淑君, 石彦, 宁艳, 等. 极速脉搏波技术在系统性红斑狼疮患者颈动脉弹性功能检测中的应用价值[J]. 中华全科医学, 2022, 20(8): 1380-1383. doi: 10.16766/j.cnki.issn.1674-4152.002602

    KONG S J, SHI Y, NING Y, et al. Application value of ultrafast pulse wave velocity in carotid artery elastic function detection in patients with systemic lupus erythematosus[J]. Chinese Journal of General Practice, 2022, 20(8): 1380-1383. doi: 10.16766/j.cnki.issn.1674-4152.002602
    [16] LAMPSAS S, XENOU M, OIKONOMOU E, et al. Lipoprotein(a) in atherosclerotic diseases: from pathophysiology to diagnosis and treatment[J]. Molecules, 2023, 28(3): 969. DOI: 10.3390/molecules28030969.
    [17] 陈群, 严远飞, 陈数, 等. 系统性红斑狼疮合并心脏损害的相关危险因素分析[J]. 实用临床医药杂志, 2022, 26(1): 109-115.

    CHEN Q, YAN Y F, CHEN S, et al. Analysis of risk factors of systemic lupus erythematosus complicated with cardiac damage[J]. Journal of Clinical Medicine in Practice, 2022, 26(1): 109-115.
    [18] MA X H, ZHU Z Q, WANG Y P, et al. Quantifying carotid stiffness in a pre-hypertensive population with ultrafast ultrasound imaging[J]. Ultrasonography, 2023, 42(1): 89-99. doi: 10.14366/usg.22039
  • 加载中
图(1) / 表(5)
计量
  • 文章访问数:  5
  • HTML全文浏览量:  4
  • PDF下载量:  0
  • 被引次数: 0
出版历程
  • 收稿日期:  2024-08-20
  • 网络出版日期:  2025-10-25

目录

    /

    返回文章
    返回